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Background: Patients with Cystic Fibrosis (CF) are at high risk for chronic airway
infection caused by Pseudomonas aeruginosa (PA). A patient, who is in 50% of the
preceding 12 months in sputum PA positive is deﬁned as having chronic infection.
A patient with no growth of PA in sputum for the previous 12 months is free of
PA infection.
Aim: Chronic inﬂammatory PA damage in respiratory tract cut down patients live
expectancy signiﬁcantly.
Method: In our paediatric CF centre there are 37 children from 0 to 18 years
periodical watched. Sputum or tracheal aspirate is bacteriological explore monthly.
In the ﬁrst evidence of PA infection is antibiotic therapy head immediately. Oral
Ciproﬂoxacin 20−30mg/kg/day q12 h minimally for 6 weeks in combination with
inhaled therapy (Colistin in children under 6 years or Tobramycin in the older ones).
We end inhaled antibiotic therapy if sputum or tracheal aspirate cultivation are 12
month for PA negative only and PCR for PA at the end of the therapy also.
Result: From 37 CF patients 12 children (32%) have no evidence of PA in their
live at all.
Other 22 children (60%) were ones or twice in their live PA infected, but they do
not suffer under chronic PA infection.
Three children (8%) are chronic infected. Two of them are years PA positive and not
treated under this therapeutic criterion. The last one refused concur (respectively
her mother), stopped antibiotic therapy early, and is chronic infected now.
Conclusion: Combined antibiotic therapy started immediately and continued long
enough can prevent chronic PA inﬂammation and deterioration of the lung function.
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Introduction: The intravenous antibiotic therapy (IAT) in Cystic Fibrosis patients
with acute pulmonary exacerbation has been utilized in reference centers around
the world.
Objectives: To evaluate the effects of IAT in clinical and spirometric parameters
and in the acute pulmonary exacerbation scores of CF patients infected with
Pseudomonas aeruginosa.
Methods: Prospective clinical study, performed in a Brazilian university hospital
from 2005 to 2007. All patients were subject to clinical and spirometric evaluation,
the Shwachman score (SS), the Cystic Fibrosis Clinical Score (CFCS), and eval-
uative scoring by the Cystic Fibrosis Foundation (CFF) before and after a 15 day
hospitalization period. All received IAT with Ceftazidime + Amicacine. Oxaciline
was added when cases were associated with the Staphylococcus aureus.
Results: 22 patients (10 male), with an average age of 16.09+6.21, and a mid
to moderate gravity of disease according to the SS. There was a statistically
signiﬁcant (p = 0.00) improvement of evaluation scores after hospitalization (CFCS
32.09+6.73 vs 19.14+4.19; CFF 6+1.88 vs 0.55+0.74). There was also gain in
weight (p = 0.002), reduction of the RF (p = 0.001) and increase of the SaO2
(p = 0.07). The spirometric variables of the forced expiratory volume within the
ﬁrst second (p = 0.006), the inspiratory capacity (p = 0.032), the slow vital capacity
(p = 0.026) and the maximum voluntary ventilation also increased (0.011) after IAT.
Conclusion: The systematization of IAT contributes to clinical and pulmonary
improvements for patients with CF.
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Airway inﬂammation is recognized as a major factor in the pathogenesis of CF
lung disease and PO prednisolone provided a beneﬁt effect in CF patients with
severe exacerbation. We reported 4 DF508/DF508 children with SRD who did not
improve by aggressive treatment and systemic corticosteroids. All were dramatically
improved by high-dose of MPSS (1g/1.73m2/day for 3 days).
Case 1: 6wks old girl admitted at birth in NICU with meconium aspiration was
still needing high mechanical support. Discontinuing the mechanical support was
discussed with the parents. A bolus of MPSS given as last resort lead to extubation 3
days later. Case 2: 3mo old boy was hospitalized for a SRD due to Staphylococcus
aureus and Pseudomonas aeruginosa infection. IV antibiotics did not improve and
he continued to require O2. Three days later IV MPSS was given, his room air SaO2
was 98% the dyspnoea disappeared. Case 3: 4 months old boy was under mechanical
ventilation in the PICU for SRD due to Staphylococcus aureus infection. 2 days
after MPSS, he was extubated and did no more require O2. Case 4: 6 yrs old boy
admitted for SRD due to Staphylococcus aureus infection, received broad spectrum
antibiotics and O2 for 2 weeks with no improvement. Two days after a bolus of
MPSS was given, O2 therapy could be stopped.
All 4 children had a Chest CT scan showing hyperinﬂation and atelectasis. The
disease features supported a severe small airway disease, which occurred early in
CF. Then, the decision to administer high dose IV MPSS was taken. This was safe
in all.
These observations suggest that giving a bolus of IV MPSS should be considered
in CF children with RSD in order to treat the associated severe small airway
inﬂammation.
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Gastro-oesophageal reﬂux (GOR) is common in CF before and after lung transplant
(LTx). Laparascopic fundoplication (LapF) is used when conservative therapy fails.
We reviewed longer term clinical outcomes of LapF in CF before & after LTx.
Methods: A 5 yr. review of patient records was undertaken. Patients completed an
outcome questionnaire at the time of the review.
Results: 37 patients underwent LapF (Complete Nissen in 30% of patients, partial
Toupet in 70%). 21 patients were transplanted (LTx Group), mean age 40 (21−67)
years, and 16 not transplanted (CF Group), 35 (22−49) yrs. Mean time between
LTx & LapF was 654 (414; 1133) days. Average length of stay: LTx Group: pre-
op.7.81; post-op.7.82 days; CF Group 5.2 & 12.5. At 6 months post-LapF there
was no signiﬁcant difference in FEV1 compared to pre-op (both groups). FEV1
remained stable to 300 days post LapF in the CF Group, p = 0.65. There was a small,
signiﬁcant decline in FEV1 in the LTx Group, p = 0.02. BMI fell in both groups
in ﬁrst 100 days post-LapF, remaining lower at 300 days post-LapF compared to
100 days pre-op, p 0.001 in the LTx Group. BMI returned to baseline 300 days
post-op in the CF Group, p = 0.47. Patient satisfaction with LapF, improvement in
symptoms & quality of life were high in both groups. There was 1 failed LapF,
2 oesophageal dilatations, 1 LOS hypotonia. Four deaths, on Days 19, 253, 284,
and 382 post-LapF, were not attributed to LapF.
Conclusions: In this series of patients there was a small but signiﬁcant drop in
FEV1 in the LTx Group 300 days after LapF, but not in the CF Group. There was
a signiﬁcant drop in BMI in both groups after LapF, but the CF Group returned to
pre LapF values at +300 days. Patient satisfaction with the procedure was high. A
long term prospective study is warranted.
